Abstract:The enzyme complex IB kinase (IKK) is an essential activator of NF-B signaling pathway involved in propagating the cellular response to inflammation. The complex contains two functional subunits IKK and IKK, which are structurally conserved kinases and selective inhibition of them would result in distinct biological effects. However, most existing IKK inhibitors show moderate or high promiscuity for the two homologous kinases. Understanding of the molecular mechanism and biological implication underlying the specific interactions in IKK-ligand recognition is thus fundamentally important for the rational design of selective IKK inhibitors. In the current work, we integrated molecular docking, quantum mechanics/molecular mechanics calculation and Poisson-Boltzmann/surface area analysis to investigate the structural basis and energetic property of the selective binding of small-molecule ligands to IKK and IKK. It was found that the selectivity is primarily determined by the size and topology difference in ATP-binding pocket of IKK and IKK kinase domains; bulky inhibitor molecules commonly have, respectively, low and appropriate affinities towards IKK and IKK, and thus exhibit relatively high selectivity for IKK over IKK, whereas small ligands can only bind weakly to both the two kinases with low selectivity. In addition, the conformation, arrangement and distribution of residues in IKK pockets are also responsible for constituting the exquisite specificity of ligand binding to KK and IKK. Next, a novel quantitative structure-selectivity relationship model was developed to characterize the relative contribution of each kinase residue to inhibitor selectivity and to predict the selectivity and specificity for a number of known IKK inhibitors. Results showed that the active-site residues contribute significantly to the selectivity by directly interacting with inhibitor ligands, while those protein portions far away from the kinase active sites may also play an important role in determining the selectivity through long-range non-bonded forces and indirect allosteric effect.

The discovery of a novel IκB kinase β inhibitor based on pharmacophore modeling, virtual screening and biological evaluation

Novel IKKβ Inhibitors Discovery Based on the Co-Crystal Structure by Using Binding-Conformation-based and Ligand-Based Method.

Pharmacophore modeling and hybrid virtual screening for the discovery of novel IκB kinase 2 (IKK2) inhibitors.

Identify promising IKK-β inhibitors: A docking-based 3D-QSAR study combining molecular design and molecular dynamics simulation

Design and Synthesis of Novel Aminoindazole-pyrrolo[2,3- b]pyridine Inhibitors of IKKα That Selectively Perturb Cellular Non-Canonical NF-κB Signalling

A Novel Allosteric Inhibitor That Prevents IKKβ Activation.

Combination Of Pharmacophore Model Development And Binding Mode Analyses: Identification Of Ligand Features Essential For I Kappa B Kinase-Beta (Ikk Beta) Inhibitors And Virtual Screening Based On It

Combination of pharmacophore model development and binding mode analyses: identification of ligand features essential for IκB kinase-beta (IKKβ) inhibitors and virtual screening based on it.

Discovery of potent inhibitors for interleukin-2-inducible T-cell kinase: structure-based virtual screening and molecular dynamics simulation approaches

IκB kinase β (IKKβ): Structure, transduction mechanism, biological function, and discovery of its inhibitors

Discovery of 5-Aryl-2,4-diaminopyrimidine Compounds as Potent and Selective IRAK4 Inhibitors.

The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway.

Identification of novel inhibitors targeting TIRAP interactions with BTK and PKCδ in inflammation through an in silico approach

Discovery of Novel Small-Molecule Inhibitors of NF-κB Signaling with Antiinflammatory and Anticancer Properties.

Recent Advances in the Structure-Based and Ligand-Based Design of IKK beta Inhibitors as Anti-inflammation and Anti-cancer Agents

Synthesis and Evaluation of Dihydrofuro[2,3-B]pyridine Derivatives As Potent IRAK4 Inhibitors

Design, Synthesis and Biological Evaluation of 4-Aminoquinoline Derivatives As Receptor-Interacting Protein Kinase 2 (RIPK2) Inhibitors

Evaluation of Artificial Intelligence in Participating Structure-Based Virtual Screening for Identifying Novel Interleukin-1 Receptor Associated Kinase-1 Inhibitors

Structure-based optimization of indoline-containing compounds as second generation inhibitors of NF-κB-inducing kinase (NIK)

Structure-based optimization of indoline-containing compounds as second generation inhibitors of NF-KB-inducing kinase (NIK)

Discovery of lupus nephritis targeted inhibitors based on De novo molecular design: comprehensive application of vinardo scoring, ADMET analysis, and molecular dynamics simulation